Mission & Founding
Mission: Make sub-clinical metabolic drift measurable and actionable using deterministic, auditable science—so institutions can intervene earlier and reduce late-stage costs.
Founded: 2026
Founders & Team
Waseem Ahmad Ahanger
CEO
- Strategy, research direction, and product vision
- Institutional partnerships and pilot execution
Mohammed Rayyan
CTO
- Infrastructure architecture and production hardening
- Data pipeline engineering and system reliability
Osama
CSO
- Scientific logic ownership (SSOT governance)
- Biomarker definitions, ingestion strategy, and validation
To partner with us, email contactus@burakomics.com.